Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccination | 5 | 2012 | 156 | 1.030 |
Why?
|
| Vaccines | 5 | 2016 | 13 | 0.990 |
Why?
|
| Influenza, Human | 5 | 2012 | 121 | 0.880 |
Why?
|
| Influenza Vaccines | 4 | 2012 | 82 | 0.830 |
Why?
|
| Medically Uninsured | 2 | 2009 | 35 | 0.570 |
Why?
|
| Immunization Programs | 4 | 2009 | 28 | 0.510 |
Why?
|
| Immunization | 4 | 2015 | 38 | 0.500 |
Why?
|
| Licensure | 1 | 2016 | 7 | 0.480 |
Why?
|
| Diffusion of Innovation | 1 | 2016 | 34 | 0.480 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2015 | 38 | 0.480 |
Why?
|
| Health Planning Guidelines | 2 | 2009 | 8 | 0.370 |
Why?
|
| Infant | 8 | 2015 | 1010 | 0.360 |
Why?
|
| Financing, Government | 1 | 2009 | 11 | 0.310 |
Why?
|
| Advisory Committees | 1 | 2009 | 35 | 0.310 |
Why?
|
| Insurance Carriers | 1 | 2009 | 18 | 0.310 |
Why?
|
| Health Priorities | 1 | 2008 | 16 | 0.270 |
Why?
|
| Smallpox Vaccine | 3 | 2007 | 6 | 0.230 |
Why?
|
| Child Welfare | 1 | 2005 | 18 | 0.230 |
Why?
|
| Disease Outbreaks | 1 | 2005 | 40 | 0.220 |
Why?
|
| Public Health | 1 | 2005 | 91 | 0.210 |
Why?
|
| Child, Preschool | 5 | 2015 | 1233 | 0.210 |
Why?
|
| United States | 8 | 2015 | 4072 | 0.190 |
Why?
|
| Child | 7 | 2011 | 2435 | 0.190 |
Why?
|
| Health Policy | 1 | 2002 | 89 | 0.170 |
Why?
|
| Adolescent | 5 | 2009 | 3519 | 0.160 |
Why?
|
| Humans | 15 | 2016 | 32282 | 0.150 |
Why?
|
| Pediatrics | 2 | 2015 | 158 | 0.140 |
Why?
|
| Mentors | 2 | 2015 | 33 | 0.130 |
Why?
|
| Drug Approval | 1 | 2016 | 13 | 0.120 |
Why?
|
| Developing Countries | 2 | 2015 | 57 | 0.120 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2015 | 2 | 0.120 |
Why?
|
| Infant, Newborn | 3 | 2015 | 666 | 0.120 |
Why?
|
| Communicable Diseases | 1 | 2015 | 17 | 0.110 |
Why?
|
| Disease Transmission, Infectious | 1 | 2015 | 16 | 0.110 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 312 | 0.100 |
Why?
|
| Smallpox | 2 | 2004 | 2 | 0.100 |
Why?
|
| Pregnancy | 2 | 2015 | 961 | 0.100 |
Why?
|
| Antiviral Agents | 2 | 2011 | 107 | 0.090 |
Why?
|
| Drug Resistance, Viral | 1 | 2011 | 9 | 0.090 |
Why?
|
| Oseltamivir | 1 | 2011 | 5 | 0.080 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 44 | 0.080 |
Why?
|
| State Medicine | 1 | 2009 | 4 | 0.080 |
Why?
|
| Private Sector | 1 | 2009 | 9 | 0.080 |
Why?
|
| National Health Insurance, United States | 1 | 2009 | 5 | 0.080 |
Why?
|
| Cross-Cultural Comparison | 1 | 2009 | 20 | 0.080 |
Why?
|
| Drug Costs | 1 | 2009 | 46 | 0.080 |
Why?
|
| Pneumonia, Viral | 1 | 2011 | 98 | 0.080 |
Why?
|
| Insurance Coverage | 1 | 2009 | 80 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 242 | 0.070 |
Why?
|
| Meningitis, Aseptic | 1 | 2007 | 1 | 0.070 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2007 | 7 | 0.070 |
Why?
|
| Data Collection | 1 | 2007 | 171 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 116 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2011 | 823 | 0.060 |
Why?
|
| Adult | 3 | 2006 | 9259 | 0.050 |
Why?
|
| Meningitis, Viral | 1 | 2003 | 2 | 0.050 |
Why?
|
| Enterovirus B, Human | 1 | 2003 | 2 | 0.050 |
Why?
|
| Coxsackievirus Infections | 1 | 2003 | 3 | 0.050 |
Why?
|
| Encephalitis, Viral | 1 | 2003 | 5 | 0.050 |
Why?
|
| Cerebral Ventricles | 1 | 2003 | 13 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2003 | 9 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2003 | 153 | 0.050 |
Why?
|
| Research Personnel | 1 | 2002 | 22 | 0.050 |
Why?
|
| Personnel Selection | 1 | 2002 | 13 | 0.050 |
Why?
|
| Schools, Medical | 1 | 2002 | 43 | 0.040 |
Why?
|
| Immunization Schedule | 1 | 2002 | 25 | 0.040 |
Why?
|
| Middle Aged | 2 | 2005 | 11851 | 0.040 |
Why?
|
| Risk | 1 | 2002 | 305 | 0.040 |
Why?
|
| Health Education | 1 | 2002 | 149 | 0.040 |
Why?
|
| Female | 2 | 2015 | 19945 | 0.040 |
Why?
|
| Immunocompromised Host | 2 | 2011 | 53 | 0.030 |
Why?
|
| Neoplasms | 1 | 2004 | 754 | 0.030 |
Why?
|
| Hospital Departments | 1 | 2015 | 2 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2015 | 42 | 0.030 |
Why?
|
| Job Satisfaction | 1 | 2015 | 39 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2015 | 171 | 0.030 |
Why?
|
| Burnout, Professional | 1 | 2015 | 54 | 0.030 |
Why?
|
| Aged | 1 | 2005 | 10263 | 0.020 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2007 | 3 | 0.020 |
Why?
|
| Safety | 1 | 2007 | 65 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2007 | 68 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2011 | 490 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2006 | 72 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2006 | 308 | 0.010 |
Why?
|
| Vaccinia | 1 | 2004 | 9 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2003 | 75 | 0.010 |
Why?
|
| Education, Graduate | 1 | 2002 | 4 | 0.010 |
Why?
|
| Epidemiology | 1 | 2002 | 5 | 0.010 |
Why?
|
| Health Planning | 1 | 2002 | 6 | 0.010 |
Why?
|
| Financing, Organized | 1 | 2002 | 17 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 2002 | 32 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2002 | 106 | 0.010 |
Why?
|
| Publishing | 1 | 2002 | 66 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2004 | 395 | 0.010 |
Why?
|
| Faculty, Medical | 1 | 2002 | 76 | 0.010 |
Why?
|
| Education, Medical, Graduate | 1 | 2002 | 131 | 0.010 |
Why?
|
| Male | 2 | 2011 | 19441 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 853 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2003 | 2240 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 1224 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2003 | 1425 | 0.010 |
Why?
|